PAVmed PAVM Stock
PAVmed Price Chart
PAVmed PAVM Financial and Trading Overview
| PAVmed stock price | 0.6 USD |
| Previous Close | 0.39 USD |
| Open | 0.41 USD |
| Bid | 0 USD x 1100 |
| Ask | 0 USD x 4000 |
| Day's Range | 0.4 - 0.44 USD |
| 52 Week Range | 0.35 - 2.34 USD |
| Volume | 436.89K USD |
| Avg. Volume | 481.08K USD |
| Market Cap | 43.65M USD |
| Beta (5Y Monthly) | 0.875704 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0.5 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 2.98 USD |
PAVM Valuation Measures
| Enterprise Value | 75.97M USD |
| Trailing P/E | N/A |
| Forward P/E | -0.6424616 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 68.85328 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 119.828 |
| Enterprise Value/EBITDA | -0.856 |
Trading Information
PAVmed Stock Price History
| Beta (5Y Monthly) | 0.875704 |
| 52-Week Change | -51.11% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 2.34 USD |
| 52 Week Low | 0.35 USD |
| 50-Day Moving Average | 0.46 USD |
| 200-Day Moving Average | 0.65 USD |
PAVM Share Statistics
| Avg. Volume (3 month) | 481.08K USD |
| Avg. Daily Volume (10-Days) | 513.04K USD |
| Shares Outstanding | 104.53M |
| Float | 95.02M |
| Short Ratio | 8.94 |
| % Held by Insiders | 9.65% |
| % Held by Institutions | 9.87% |
| Shares Short | 4.6M |
| Short % of Float | 4.71% |
| Short % of Shares Outstanding | 4.39% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -14462.61% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -76.60% |
| Return on Equity (ttm) | -280.17% |
Income Statement
| Revenue (ttm) | 634K USD |
| Revenue Per Share (ttm) | 0.007 USD |
| Quarterly Revenue Growth (yoy) | 136.00% |
| Gross Profit (ttm) | -3237000 USD |
| EBITDA | -88725000 USD |
| Net Income Avi to Common (ttm) | -90329000 USD |
| Diluted EPS (ttm) | -0.95 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 52.81M USD |
| Total Cash Per Share (mrq) | 0.51 USD |
| Total Debt (mrq) | 49.5M USD |
| Total Debt/Equity (mrq) | 458.16 USD |
| Current Ratio (mrq) | 1.065 |
| Book Value Per Share (mrq) | -0.247 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -75009000 USD |
| Levered Free Cash Flow (ttm) | -46481500 USD |
Profile of PAVmed
| Country | United States |
| State | NY |
| City | New York |
| Address | 360 Madison Avenue |
| ZIP | 10017 |
| Phone | 212 949 4319 |
| Website | https://www.pavmed.com |
| Industry | Medical Devices |
| Sector(s) | Healthcare |
| Full Time Employees | 124 |
PAVmed Inc. operates as a medical device company in the United States. The company's lead products include CarpX, a patented, single-use, disposable, and minimally invasive surgical device for use in the treatment of carpal tunnel syndrome; and EsoCheck, an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett's Esophagus (BE); and EsoGuard, a bisulfite-converted next-generation sequencing DNA assay. Its product pipeline also comprises EsoCure, an esophageal ablation device to treat dysplastic BE; PortIO, an implantable intraosseous vascular access device; NextFlo; and Veris cancer care platform. The company was formerly known as PAXmed Inc. and changed its name to PAVmed Inc. in April 2015. PAVmed Inc. was incorporated in 2014 and is headquartered in New York, New York.
Q&A For PAVmed Stock
What is a current PAVM stock price?
PAVmed PAVM stock price today per share is 0.6 USD.
How to purchase PAVmed stock?
You can buy PAVM shares on the NasdaqCM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for PAVmed?
The stock symbol or ticker of PAVmed is PAVM.
Which industry does the PAVmed company belong to?
The PAVmed industry is Medical Devices.
How many shares does PAVmed have in circulation?
The max supply of PAVmed shares is 16.46M.
What is PAVmed Price to Earnings Ratio (PE Ratio)?
PAVmed PE Ratio is 1.20000000 now.
What was PAVmed earnings per share over the trailing 12 months (TTM)?
PAVmed EPS is 0.5 USD over the trailing 12 months.
Which sector does the PAVmed company belong to?
The PAVmed sector is Healthcare.
PAVmed PAVM included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 15603.26 USD — |
+0.1
|
10.08B USD — | 14784.03 USD — | 16292.28 USD — | — - | 10.08B USD — |
| NASDAQ Capital Market Composite RCMP | 91.92 USD — |
-0.27
|
— — | 86.91 USD — | 95.14 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 865.57 USD — |
-0.49
|
— — | 828.4 USD — | 890 USD — | — - | — — |
- {{ link.label }} {{link}}